Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -11314.24% is 5530% below its 3-year average of -200.96%, near the high end of its 3-year range (-110484.25%–0.00%).
74.19% above its 12-month average of -43839.60%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2009.64%.
NET PROFIT MARGIN
-11314.24%
NET PROFIT MARGIN AVG TTM
-43839.60%
NET PROFIT MARGIN AVG 3Y
-200.96%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+74.19%
CURRENT VS 3Y AVG
-5529.99%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
Net Profit Margin
-11314.24%
TTM Avg
-43839.60%
3Y Avg
-200.96%
5Y Avg
0.00%
Market Cap
$1.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11M
Net Profit Margin
-8.46%
TTM Avg
-4.30%
3Y Avg
1.83%
5Y Avg
1.83%
Market Cap
$1.21M
Net Profit Margin
-14220.12%
TTM Avg
-19831.38%
3Y Avg
-10446.98%
5Y Avg
-7103.54%
Market Cap
$1.17M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$851060.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$873967.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$856468.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$1.16M
Net Profit Margin
-38.08%
TTM Avg
-20.13%
3Y Avg
-101.84%
5Y Avg
-106.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | -11314.24% | -43839.60% | -200.96% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | -8.46% | -4.30% | 1.83% | 1.83% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.21M | -14220.12% | -19831.38% | -10446.98% | -7103.54% |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $851060.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $856468.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | -38.08% | -20.13% | -101.84% | -106.69% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $834083.00 | 0.00% | 0.00% | -933.28% | -622.19% |
Operating Margin
-312017.0%
Net Profit Margin
-11314.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2009.64% |
| 2026-03-31 | -11367.02% |
| 2025-12-31 | -110484.25% |
| 2025-09-30 | -95337.09% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |